CClinicalTrials.gg
CompletedNCT07258017Updated Dec 2, 2025

Impact of Interactive Video Health Intervention on Quality of Life After Bowel Obstruction Surgery

An interventional study of Conventional care and Interactive Video Health Intervention in Intestinal Obstruction and Postoperative Complications, sponsored by Changsha Fourth Hospital. Completed at 1 site in China. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2025-12-02.

Sponsored by Changsha Fourth Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
462
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

Objective: To investigate the multidimensional effects of an interactive video health intervention on the quality of life and clinical rehabilitation indicators of patients with early postoperative bowel obstruction.

Methods: The study consists of two phases. Phase 1 (January 2019-December 2020) involves the development and psychometric validation of a Postoperative Quality of Life Assessment Scale for Early Intestinal Obstruction, with approximately 150 patients. Phase 2 (January 2021-January 2025) is a randomized controlled trial enrolling about 310 eligible patients (aged 18-75 years, with basic cognitive ability, diagnosed with early postoperative bowel obstruction after abdominal surgery). Participants are randomly assigned to either a control group (conventional care, including condition monitoring, basic treatment, and non-structured health education) or a study group (conventional care plus an interactive video health intervention consisting of five modular videos covering disease knowledge, rehabilitation, and diet, initiated 24 hours post-surgery).

Primary and secondary outcomes will include quality of life (assessed with the validated scale), clinical rehabilitation indicators (such as obstruction relief time and hospitalization duration), electrogastrogram parameters, and gut microbiota diversity (16S rRNA sequencing).

02

Conditions studied

  • Intestinal Obstruction
  • Postoperative Complications
03

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients diagnosed with early postoperative intestinal obstruction after abdominal surgery based on clinical symptoms, physical examination and imaging
  • Aged between 18 and 75 years
  • With basic cognitive ability and comprehension
  • Informed consent obtained directly from patients; family members provided supplementary consent

Exclusion criteria

Exclusion Criteria:

  • Serious underlying diseases
  • Serious mental diseases
  • Audio-visual impairment that prevents normal reception of interactive video information
  • Poor compliance
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
462 participants (actual)

Study arms

  • Active comparator
    Conventional Care Control Group

    Behavioral: Conventional care

  • Experimental
    Interactive Video Health Intervention Group

    Behavioral: Interactive Video Health Intervention

Interventions

  • BehavioralConventional care

    Standard conventional care including condition monitoring, basic medical treatment (gastrointestinal decompression, fluid replacement, correction of water-electrolyte disorders), and non-structured health education. Represents the current standard of care for postoperative bowel obstruction patients without the additional video-based intervention component.

  • BehavioralInteractive Video Health Intervention

    A structured interactive video intervention consisting of 5 modular videos covering disease knowledge, rehabilitation exercises, and dietary guidance. The videos use animation demonstrations, case analyses, and expert explanations, with interactive elements such as Q\&A sessions and polls. Initiated 24 hours post-surgery, patients can self-paced viewing using tablet devices with researcher support.

05

What researchers measure

Primary outcomes

  1. Quality of Life (QoL) Score

    Scale consists of multiple domains assessing physical, psychological, and social functioning. Scores range from 0 to 100, with higher scores indicating better quality of life.

    Time frame: Baseline (pre-intervention, within 24 hours after surgery) and at hospital discharge (average 8-10 days after randomization).

Secondary outcomes

  1. Time to Relief of Intestinal Obstruction

    Time from randomization to relief of intestinal obstruction symptoms (abdominal pain, distension, and resumption of defecation/flatus), measured in hours using daily clinical evaluation and patient report.

    Time frame: From randomization to hospital discharge (daily assessment, average 8-10 days)

  2. Duration of Hospitalization

    Total number of days from the date of surgery to the date of hospital discharge, as recorded in hospital medical records. This indicator reflects postoperative recovery efficiency and the impact of the interactive video intervention on clinical outcomes.

    Time frame: From the day of surgery through hospital discharge (an average of 7-10 days)

  3. Electrogastrogram (EGG) Parameters - Gastric Antrum Slow-Wave Amplitude

    Gastric antrum slow-wave amplitude measured in microvolts (μV) using electrogastrogram at specified time points.

    Time frame: 24 hours post-intervention initiati

  4. Electrogastrogram (EGG) Parameters - Gastric Slow-Wave Frequency

    Gastric slow-wave frequency measured in cycles per minute (cpm) using electrogastrogram at specified time points.

    Time frame: 24 hours post-intervention initiation and

  5. Title: Gut Microbiota Diversity (Shannon Index)

    Alpha diversity of gut microbiota measured by Shannon index using 16S rRNA sequencing of fecal samples.

    Time frame: First postoperative defecation (typically 3-5 days post-surgery)

Other outcomes

  1. Postoperative Quality of Life Assessment Scale Validation - Reliability Metrics

    Internal consistency of the Postoperative Quality of Life Assessment Scale for Early Intestinal Obstruction, assessed using Cronbach's alpha (range 0-1; higher scores indicate better internal consistency).

    Time frame: At postoperative day 7 (single assessment after intervention)

  2. Postoperative Quality of Life Assessment Scale Validation - Construct Validity Metrics

    Construct validity of the Postoperative Quality of Life Assessment Scale for Early Intestinal Obstruction (PQOL-EO), assessed using Average Variance Extracted (AVE) and Composite Reliability (CR). Both are unitless indices (range 0-1), where higher values indicate better construct validity and internal consistency of the scale.

    Time frame: At postoperative day 7 (single assessment after intervention)

  3. Expert Consensus Agreement on Questionnaire Items

    Percentage of questionnaire items rated as "appropriate" or "highly relevant" by an expert panel using a 5-point Likert scale (1 = not relevant to 5 = highly relevant). Higher scores indicate greater content validity and expert consensus regarding the Postoperative Quality of Life Assessment Scale for Early Intestinal Obstruction (PQOL-EO).

    Time frame: During the pre-intervention development phase (single assessment prior to participant enrollment)

06

Study locations

1 site
  • The Fourth Hospital of Changsha
    Changsha, Hunan 410006, China
07

References and documents

Publications

  • Yao L, Wu D, Liu J, Zhang X, Zhang L. Multidimensional impact analysis of interactive video health intervention on quality of life and clinical rehabilitation indicators in patients with early postoperative bowel obstruction: a randomized controlled trial. Int J Colorectal Dis. 2026 Jan 8;41(1):19. doi: 10.1007/s00384-025-05051-0. PubMed 41507597 ↗
08

Registry details

Key details

Study ID
NCT07258017
Lead sponsor
Changsha Fourth Hospital
Responsible party
Li Zhang (Principal Investigator, Changsha Fourth Hospital) — Principal investigator
First posted
Dec 2, 2025
Start date
Jan 10, 2019
Primary completion
Jan 13, 2025
Completion
Jan 24, 2025
Last update
Dec 2, 2025

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion